April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Role of Vimentin in Regulation of Cell Spreading during Early Stages of Corneal Fibrosis
Author Affiliations & Notes
  • Paola Bargagna-Mohan
    Neuroscience, Univ of Connecticut Health Center, Farmington, CT
  • Ling Lei
    Neuroscience, Univ of Connecticut Health Center, Farmington, CT
  • Anthony Shelley
    Computer and Electrical Engeneering, University of Kentucky, Lexington, KY
  • Eric C Mohan
    Biology, Hall High School, West Hartford, CT
  • Cindy Caruk
    Biology, Hall High School, West Hartford, CT
  • Daniel L Lau
    Computer and Electrical Engeneering, University of Kentucky, Lexington, KY
  • Royce Mohan
    Neuroscience, Univ of Connecticut Health Center, Farmington, CT
  • Footnotes
    Commercial Relationships Paola Bargagna-Mohan, University of Kentucky (P); Ling Lei, None; Anthony Shelley, None; Eric Mohan, None; Cindy Caruk, None; Daniel Lau, None; Royce Mohan, University of kentucky (P)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4703. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Paola Bargagna-Mohan, Ling Lei, Anthony Shelley, Eric C Mohan, Cindy Caruk, Daniel L Lau, Royce Mohan; Role of Vimentin in Regulation of Cell Spreading during Early Stages of Corneal Fibrosis. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4703.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Soluble vimentin (sVim) along with its cytoskeletal filamentous form (fVim) are expressed during corneal fibrosis. Vimentin is known to promote cell adhesion and spreading through interactions with filamin A (FLNa), an actin cross-linking protein involved in tissue remodeling and wound healing. Here we have investigated withaferin A (WFA) as a chemical probe of sVim during early events of cell adhesion and spreading.

Methods: We exploited a cell culture model of cell spreading using primary rabbit corneal stromal fibroblast cells (RbCFs). Cells between 2nd and 8th passage were serum starved, trypsinized and allowed to re-attach in presence or absence of WFA in culture medium containing 10% serum. Cell behavior was analyzed by a computer software algorithm. Expression of sVim, phosphorylated (Ser38)-sVim, and FLNa were analyzed by immunohistochemistry and western blot at different time points.

Results: WFA binding to sVim affected cell spreading within 60 minutes of treatment. Interestingly, we found that cell passage was a key feature in driving cell attachment; RbCF2 cells had a 3-fold and RbCF5 a 2-fold higher replating rate than RbCF8 cells within 1 hour-post-adhesion. WFA treatment (1 μΜ) did not significantly alter the rate of adhesion in each cell group, suggesting a non-toxic effect of the drug. Also, cell spreading and cell shape changes were clearly influenced by cell passage number. Majority of RbCF2 and RbCF5 cells spread with an anisotropic shape and displayed a complete assembly of fVim within 1 h post-plating, whereas RbCF8 cells maintained an isotropic shape and showed a less extensive vimentin staining pattern. Soluble protein extracts analyzed by western blots showed no significant changes in both sVim and p-Ser38vim expression in RbCF2 and RbCF5 cells after WFA treatment; however, WFA-treated RbCF8 cells displayed a 5-fold decrease in vimentin expression with appearance of high molecular weight p-Ser38Vim isoforms. RbCF8 cells displayed a 2-fold decrease in soluble FLNa after WFA treatment compared to RbCF2 cells.

Conclusions: We show that modulation of sVim by WFA regulates its interactions with FLNa in a manner dependent on cell passage. As corneal fibroblasts are known to advance into a myofibroblastic phenotype with cell passage, our findings underscore a novel role for sVim as a target for differentially controlling myofibroblastic behavior during fibrosis.

Keywords: 484 cornea: stroma and keratocytes • 533 gene/expression • 765 wound healing  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×